CMML2AML: machine-learning discovery of co-mutations and specific single mutations predictive of blast transformation in chronic myelomonocytic leukemia. [PDF]
Fathima S +19 more
europepmc +1 more source
One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol. [PDF]
Yousuf M +17 more
europepmc +1 more source
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia. [PDF]
Lanino L +50 more
europepmc +1 more source
Editorial: Biomarkers and precision medicine in myeloid neoplasms. [PDF]
Datta Mitra A.
europepmc +1 more source
Venetoclax-Based Regimens in Chronic Myelomonocytic Leukemia: A Systematic Review and Meta-Analysis.
Abdulgayoom M +7 more
europepmc +1 more source
Predicting response to hypomethylating agents in myeloid neoplasms: a robust model. [PDF]
Guo C, Gao YY, Ju QQ, Li ZL.
europepmc +1 more source
Chronic myelomonocytic leukemia (CMML) is a rare and challenging type of myeloproliferative neoplasm. Poor prognosis and high mortality, associated predominantly with progression to secondary acute myeloid leukemia (sAML), is still an unsolved problem ...
Ekaterina Belotserkovskaya +1 more
exaly +4 more sources
Related searches:
Oligo-Monocytic CMML and Other Pre-CMML States: Clinical Impact, Prognostication and Management
Best Practice and Research in Clinical Haematology, 2020Chronic myelomonocytic leukemia (CMML) is defined by myelodysplasia, pathologic accumulation of monocytes and a substantial risk to transform to secondary acute myeloid leukemia (sAML). In recent years, minimal diagnostic criteria for classical CMML and CMML-variants were proposed.
Peter Valent
exaly +3 more sources
Characterization of CMML with Normal Karyotype in Comparison to CMML with Aberrant Karyotype
Blood, 2015Abstract Background: CMML is a myelodysplastic/myeloproliferative neoplasm with distinct morphological and genetic features. Based on differences in blast count CMML is divided into CMML-1 (<1% blasts in the peripheral blood (pB) and <10% in the bone marrow (BM)) and CMML-2 (5-19% blasts in pB, 10-19% in BM or presence of Auer rods)
Claudia Haferlach +4 more
openaire +1 more source
CMML: Clinical and molecular aspects
International Journal of Hematology, 2017Chronic Myelomonocytic Leukemia is a chronic myeloid neoplasm occurring mostly in the elderly with overlapping features of myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN) characterized by chronic monocytosis. Recent progresses in the molecular and cellular pathogenesis of CMML have stirred a renewed interest in this clinically ...
Raphael, Itzykson +3 more
openaire +2 more sources

